Loading clinical trials...
Loading clinical trials...
The purpose of this research study is to measure synaptic density in the brain comparing individuals with cocaine use disorder to healthy controls.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Yale University
Collaborators
NCT07109245 · Brain Insulin Sensitivity, Healthy Controls, and more
NCT07227948 · Cocaine Use Disorder
NCT06780917 · Mild Cognitive Impairment (MCI), Major Depressive Disorder, Remitted, and more
NCT07284290 · Dementia With Lewy Bodies, Parkinson Disease Dementia, and more
NCT07071779 · Alcohol Use Disorder (AUD), Cocaine Use Disorder (CUD), and more
Connecticut Mental Health Center
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions